IMMUNOHISTOCHEMICAL EXPRESSION OF P57 IN PLACENTAL VASCULAR PROLIFERATIVE DISORDERS OF PRETERM AND TERM PLACENTAS

REFERENCES

• Jun S Y, Ro J Y, Kim K R. p57kip2 is useful in the classification and differential diagnosis of complete and partial hydatiform moles. Histopathology 2003; 43: 17–25
   PubMedGoogle Scholar
• Romaguera R L, Rodriguez M M, Bruce J H, et al. Molar gestations and hydropic abortions differentiated by p57 immunostaining. Fetal Pediatr Pathol 2004; 23: 181–190
   Web of Science ®Google Scholar
• Anderson J, Gordon A, McManus A, Shipley J, Pritchard-Jones K. Disruption of imprinted genes at chromosome region 11p15.5 in paediatric rhabdomyosarcoma. Neoplasia 1999; 1: 340–348
   PubMedGoogle Scholar
• Orlow I, Iavarone A, Crider-Miller S J, et al. Cyclin-dependant kinase inhibitor p57KIP2 in soft tissue sarcomas and Wilms' tumors. Cancer Res 1996; 56: 1219–1221
   Google Scholar
• Cohen M. Beckwith-Wiedemann syndrome: historical, clinicopathological and ethiopathogenic perspectives. Pediatr Develop Pathol 2005; 8: 287–304
   PubMed Web of Science ®Google Scholar
• Chen C P. Syndromes and disorders associated with omphalocele (I): Beckwith-Wiedemann syndrome. Taiwan J Obstet Gynecol 2007; 46: 96–102
   Google Scholar
• Matsuura T, Takahashi K, Nakayama K, et al. Increased expression of vascular endothelial growth factor in placentas of p57(Kip2) null embryos. FEBS Lett 2002; 532: 283–288
   Google Scholar
• Drut R, Drut R M. Expression of p57 in infantile hemangioma. J Mol Hist 2005; 36: 195–197
   Google Scholar
• Soma H, Osawa H, Oguro T, et al. p57kip2 immunohistochemical expression and ultrastructural findings of gestational trophoblastic disease and related disorders. Med Mol Morphol 2007; 40: 95–102
   Google Scholar
• Hoffner L, Dunn J, Esposito N, Macpherson T, Surti U. p57(kip2) immunostaining and molecular cytogenetics:combined approach aids in diagnosis of morphologically challenging cases with molar phenotype and in detecting androgenetic cell lines in mosaic/chimerism conceptions. Hum Pathol 2008; 39: 63–72
   PubMed Web of Science ®Google Scholar
• Ogino S, Redline R W. Villous capillary lesions of the placenta: distinctions between chorangioma, chorangiomatosis and chorangiosis. Hum Pathol 2000; 31: 945–954
   PubMed Web of Science ®Google Scholar
• Kraus F T, Redline R W, Gersell D J, Nelson D M, Dicke J M. Disorders of placental development. In Atlas of Nontumor Pathology. Placental Pathology, D W King. AFIP, Washington 2004; 47–74
   Google Scholar
• Jauniaux E, Nicolaides K H, Hustin J. Perinatal features associated with placental mesenchymal dysplasia. Placenta 1997; 18: 701–706
   PubMed Web of Science ®Google Scholar
• Paradinas F J, Sebire N J, Fisher R A, et al. Pseudo-partial moles: placental stem vessel hydrops and the association with Beckwith-Wiedemann syndrome and completes moles. Histopathology 2001; 39: 447–454
   PubMed Web of Science ®Google Scholar
• Arizawa M, Nakayama M. Suspected involvement of the X chromosome in placental mesenchymal dysplasia. Cong Anomal 2002; 42: 309–317
   PubMedGoogle Scholar
• Pham T, Steele J, Stayboldt C, Chan L, Benirschke K. Placental mesenchymal dysplasia is associated with high rates of intrauterine growth restriction and fetal demise: a report of 11 new cases and a review of the literature. Am J Clin Pathol 2006; 126: 67–78
   PubMed Web of Science ®Google Scholar
• Parveen Z, Tongson-Ignacio J E, Fraser C R, Killeen J L, Thompson K S. Placental mesenchymal dysplasia. Arch Pathol Lab Med 2007; 131: 131–137
   PubMed Web of Science ®Google Scholar
• Matsui H, Iitsuka Y, Yamazawa K, et al. Placental mesenchymal dysplasia initially diagnosed as partial mole. Pathol Int 2003; 53: 810–813
   PubMed Web of Science ®Google Scholar
• Feinberg R F, Lockwood C J, Salafia C, Hobbins J C. Sonographic diagnosis of a pregnancy with diffuse hydatiform mole and coexistent 46,XX fetus: a case report. Obstet Gynecol 1988; 72: 485–488
   PubMedGoogle Scholar
• Benirschke K, Kaufman P, Baergen R N. Anatomy and pathology of the placental membranes. Pathology of the Human Placenta, 5th ed, K Benirschke, P Kaufman, R N Baergen. Springer-Verlag, New York 2006; 321–379
   Google Scholar
• Bianchi D W, Wilkins-Haug L E, Enders A C, Hay E D. Origin of extraembryonic mesoderm in experimental animals: relevance to chorionic mosaicism in humans. Am J Med Genet 1993; 46: 542–550
   PubMed Web of Science ®Google Scholar
• Robinson W P, McFadden D E, Barrett I J, et al. Origin of amnion and implications for evaluation of the fetal genotype in cases of mosaicism. Prenat Diagn 2002; 22: 1076–1085
   Google Scholar
• Robinson W P, Lauzon J L, Innes A M, Lim K, Arsovska S, McFadden D E. Origin and outcome of pregnancies affected by androgenetic/biparental chimerism. Hum Reprod 2007; 22: 1114–1122
   PubMed Web of Science ®Google Scholar
• Kaiser-Rogers K A, McFadden D E, Livasy C A, et al. Androgenetic/biparental mosaicism causes placental mesenchymal dysplasia. J Med Genet 2006; 43: 187–192
   PubMed Web of Science ®Google Scholar
• Surti U, Hill L M, Dunn J, Prosen T, Hoffner L. Twin pregnancy with a chimeric androgenetic and biparental placenta in one twin displaying placental mesenchymal dysplasia phenotype. Prenat Diagn 2005; 25: 1048–1056
   PubMedGoogle Scholar
• Wilson M, Peters G, Bennets B, et al. The clinical phenotype of mosaicism for genome-wide paternal uniparental disomy: two new reports. Am J Med Genet 2008; 146: 137–148
   Google Scholar
• Schuetzle M N, Huphoff T S, Hatten B A, Dawson D B. Utility of microsatellite analysis in evaluation of pregnancies with placental mesenchymal dysplasia. Prenat Diagn 2007; 27: 1238–1244
   Google Scholar
• Højberg K E, Aagaard J, Henriques U, Sunde L. Placental vascular malformation with mesenchymal hyperplasia and a localized chorangioma. A rarity simulating partal mole. Path Res Pract 1994; 190: 808–813
   PubMed Web of Science ®Google Scholar
• Chen C P, Chern S R, Wang T Y, Huang M C, Chuang C Y. Pregnancy with concomitant chorangioma and placental vascular malformation with mesenchymal hyperplasia. Hum Reprod 1997; 12: 2553–2556
   PubMedGoogle Scholar
• Robinson W P, Slee J, Smith N, et al. Placental mesenchymal dysplasia associated with fetal overgrowth and mosaic deletion of the maternal copy of 11p15.5. Am J Med Genet A 2007; 143: 1752–1759
   Google Scholar
• Fisher R A, Hodges M D, Rees H C, et al. The maternally transcribed gene p57(KIP2) (CDKN1C) is abnormally expressed in both androgenetic and biparental complete hydatiform moles. Hum Mol Genet 2002; 11: 3267–3272
   PubMed Web of Science ®Google Scholar
• El-Maari O, Seoud M, Coullin P, et al. Maternal alleles acquiring paternal methylation patterns in biparental complete hydatiform moles. Hum Mol Genet 2003; 12: 1405–1413
   Google Scholar
• Rakheja D, Margraf L R, Tomlinson G E, Schneider N R. Hepatic mesenchymal hamartoma with translocation involving chromosome band 19q13.4: a recurrent abnormality. Cancer Genet Cytogenet 2004; 153: 60–63
   PubMedGoogle Scholar
• Talmon G A, Cohen S M. Mesenchymal hamartoma of the liver with an interstitial deletion involving chromosome band 19q13.4: a theory as to pathogenesis?. Arch Pathol Lab Med 2006; 130: 1216–1218
   Google Scholar
• Kitano Y, Ruchelli E, Weiner S, Adzicck N S. Hepatic mesenchymal hamartoma associated with mesenchymal stem villous hyperplasia of the placenta. Fetal Diagn Ther 2000; 15: 134–138
   PubMed Web of Science ®Google Scholar
• Aldwaidh M H, Woodhall C R, Carty H T. Mesenchymal hamartoma of the liver: a case report. Pediatr Radiol 1997; 27: 247–249
   Google Scholar
• Laberge J M, Patenaude Y, Desilets V, et al. Large hepatic mesenchymal hamartoma leading to mid-trimester fetal demise. Fetal Diagn Ther 2005; 20: 141–145
   Google Scholar
• Francis B, Hallam L, Kecskes Z, Ellwood D, Croaker D, Kent A. Placental mesenchymal dysplasia associated with hepatic mesenchymal hamartoma in the newborn. Pediatr Dev Pathol 2007; 10: 50–54
   Google Scholar